Columbia University Mailman School of Public Health, 722 W 168th St, New York, NY, 10032, United States.
Columbia University Mailman School of Public Health, 722 W 168th St, New York, NY, 10032, United States.
Drug Alcohol Depend. 2020 Jan 1;206:107654. doi: 10.1016/j.drugalcdep.2019.107654. Epub 2019 Nov 2.
Criminal justice referral to treatment is associated with reduced odds of receiving opioid agonist treatment (OAT), the gold-standard treatment for opioid use disorder. States vary substantially in the extent of criminal justice system involvement in opioid treatment; however, the effects on treatment provision are not clear. We examined whether state-level criminal justice involvement in the substance use treatment system modified the association between criminal justice referral to treatment and OAT provision among opioid treatment admissions.
We conducted a random effects logistic regression to investigate how the effects of criminal justice referral to treatment on OAT provision differed in states with high vs. low state-level criminal justice involvement in opioid treatment, adjusting for individual and state-level covariates, among 22 states in the 2015 Treatment Episode Dataset-Admissions.
Criminal justice referral to treatment was associated with an 85% reduction in the odds of receiving OAT, compared to other sources of treatment referral (OR = 0.15; 95% CI: 0.15, 0.16). Among opioid treatment admissions resulting from criminal justice referral in 2015, receiving treatment in high criminal justice involvement states was associated with a 63% reduction in the odds of OAT provision, compared to opioid treatment received in low criminal justice involvement states (interaction OR = 0.37, 95% CI: 0.11, 0.89).
The effects of criminal justice referral to treatment on OAT provision varied by criminal justice involvement in opioid treatment at the state level. Targeted interventions should increase access to OAT in states that rely on the criminal justice system for opioid treatment referrals.
与接受阿片类药物激动剂治疗(OAT)的可能性降低相关的刑事司法转介治疗是治疗阿片类药物使用障碍的金标准。各州在刑事司法系统参与阿片类药物治疗的程度上存在很大差异;然而,其对治疗提供的影响尚不清楚。我们研究了物质使用治疗系统中州一级刑事司法参与是否改变了刑事司法转介治疗与阿片类药物治疗入院者接受 OAT 治疗之间的关联。
我们进行了随机效应逻辑回归,以调查在州一级刑事司法参与阿片类药物治疗程度较高与较低的州,刑事司法转介治疗对 OAT 提供的影响是否存在差异,调整了个体和州一级的协变量,共涉及 2015 年治疗案例数据集-入院的 22 个州。
与其他治疗转介来源相比,刑事司法转介治疗与接受 OAT 的几率降低了 85%(OR=0.15;95%CI:0.15,0.16)。在 2015 年因刑事司法转介而接受阿片类药物治疗的入院者中,与在刑事司法参与程度较低的州接受治疗相比,在刑事司法参与程度较高的州接受治疗与 OAT 提供的几率降低了 63%(交互 OR=0.37,95%CI:0.11,0.89)。
刑事司法转介治疗对 OAT 提供的影响因州一级阿片类药物治疗中的刑事司法参与程度而异。有针对性的干预措施应增加在依赖刑事司法系统进行阿片类药物治疗转介的州获得 OAT 的机会。